Feasibility Study of Genomic Sequencing to Find Potential Targets for Personalized Therapy
NCT01869218
·
clinicaltrials.gov ↗
COMPLETED
Status
40
Enrollment
OTHER
Sponsor class
Conditions
Hematologic Neoplasms
Sponsor
University of Colorado, Denver